(August 22, 2024, 8:05 AM EDT) -- NASHVILLE, Tenn. — Novo Nordisk Inc., a drug manufacturer that says it’s the only company with approval from the U.S. Food and Drug Administration to produce medicine containing the molecule semaglutide, survived a motion to dismiss filed by a pharmacy that it sued for selling products that contain semaglutide, but the Tennessee federal judge granted permission for the pharmacy to raise its arguments again....